LidoSpra

Spray · Topical

Prescription (Rx) Amide Local Anesthetic Antiarrhythmic

Uses

LidoSpra™ is indicated for topical analgesia and for the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, minor skin irritations, and rashes due to poison ivy, poison oak, or poison sumac, or as directed by a healthcare provider.

Dosage and administration

Spray the affected area in sufficient quantity 2 to 4 times daily as needed or as directed by a healthcare provider.

Contraindications

LidoSpra™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.

Warnings

For external use only. Avoid contact with eyes. If irritation, sensitivity, or infection occurs, discontinue use. Keep out of reach of children.

Precautions

Use only as directed. Excessive application may result in increased systemic absorption of lidocaine.

Description

LidoSpra™ is a topical spray containing Lidocaine 4.12%.

How supplied

LidoSpra™ (Lidocaine 4.12%) is supplied as a topical spray in a 30 mL (1 fl oz) container. NDC 85477-325-29 Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.]

Label text from the FDA structured product label by Oncora Pharma, LLC (revised Aug 25, 2026). Long sections are shortened; the complete label is on DailyMed.

Active ingredients

LidoSpra NDC products (1)

NDCStrength & formLabelerType
85477-325Lidocaine 41.2 mg/mL
Spray
Oncora Pharma, LLCUNAPPROVED DRUG OTHER

Frequently asked questions

What is LidoSpra used for?

LidoSpra™ is indicated for topical analgesia and for the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, minor skin irritations, and rashes due to poison ivy, poison oak, or poison sumac, or as directed by a healthcare provider.

Who makes LidoSpra?

LidoSpra is listed by 1 labeler in the FDA NDC directory, including Oncora Pharma, LLC.